(Q34113319)

31 July 2017

1 reference

title

The future of antiplatelet therapy: optimizing management in patients with acute coronary syndrome (English)

1 reference

11129683

31 July 2017

main subject

acute coronary syndrome

1 reference

1

Topol EJ

E J Topol

2 references

11129683

31 July 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655225&resulttype=core&format=json

15 May 2020

publication date

1 November 2000

1 reference

31 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655225&resulttype=core&format=json

15 May 2020

volume

23 Suppl 6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655225&resulttype=core&format=json

15 May 2020

page(s)

VI-23-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655225&resulttype=core&format=json

PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement

15 May 2020

cites work

1 reference

12 December 2020

Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin

1 reference

12 December 2020

Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation

1 reference

12 December 2020

Significance of soluble P-selectin, von Willebrand factor, and other adhesion molecules in hypercholesterolemia and peripheral artery disease

1 reference

12 December 2020

Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease

1 reference

12 December 2020

Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications

1 reference

12 December 2020

Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: study design of the sibrafiban versus aspirin to yield maximum protection from ischemic heart events post-acute coronary syndromes (SYM

1 reference

12 December 2020

Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes

1 reference

12 December 2020

Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel

1 reference

12 December 2020

Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation

1 reference

12 December 2020

Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting

1 reference

12 December 2020

Ticlopidine and clopidogrel

1 reference

12 December 2020

Clopidogrel as adjunctive antiplatelet therapy during coronary stenting

1 reference

12 December 2020

Clopidogrel versus ticlopidine after intracoronary stent placement

1 reference

12 December 2020

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

1 reference

12 December 2020

Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study

1 reference

12 December 2020

Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial Infarction

1 reference

12 December 2020

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

1 reference

12 December 2020

Synergy, additivism and antagonism in immunosuppression. A critical review

1 reference

12 December 2020

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

12 December 2020

Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients

1 reference

12 December 2020

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

12 December 2020

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures

1 reference

12 December 2020

Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II

1 reference

12 December 2020

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study

1 reference

12 December 2020

Antiplatelet effect of ticlopidine after coronary stenting

1 reference

12 December 2020

Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tiro

1 reference

12 December 2020

Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease

1 reference

12 December 2020

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

1 reference

12 December 2020

Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

1 reference

12 December 2020

Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation

1 reference

12 December 2020

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

12 December 2020

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

12 December 2020

Cloning and characterization of human protease-activated receptor 4

1 reference

12 December 2020

Platelet glycoprotein IIIa polymorphism and coronary thrombosis

1 reference

12 December 2020

Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis

1 reference

12 December 2020

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

1 reference

12 December 2020

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

12 December 2020

A dual thrombin receptor system for platelet activation

1 reference

12 December 2020

The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit

1 reference

12 December 2020

Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors

1 reference

12 December 2020

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

1 reference

12 December 2020

Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis

1 reference

12 December 2020

Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates

1 reference

12 December 2020

Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40

1 reference

12 December 2020

Platelet GPIIb-IIIa blockers

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.4960231107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655225&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655225&resulttype=core&format=json

15 May 2020

11129683

1 reference